Type II Raf kinase inhibitors

Details for Australian Patent Application No. 2010343102 (hide)

Owner Dana-Farber Cancer Institute, Inc.

Inventors Gray, Nathanael S.

Agent Pizzeys

Pub. Number AU-A-2010343102

PCT Pub. Number WO2011/090738

Priority 61/290,884 29.12.09 US

Filing date 29 December 2010

Wipo publication date 28 July 2011

International Classifications

C07D 241/20 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/4965 - Non-condensed pyrazines

A61K 31/497

A61P 35/00 Antineoplastic agents

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/090738 Priority application(s): WO2011/090738

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010343103-Methods and systems for power generation by changing density of a fluid

2010343097-Production of high strength titanium alloys